Fortrea Holdings (FTRE) Enterprise Value (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Enterprise Value came in at -$168.6 million in Q2 2026, down 107.64% YoY from $2.2 billion in Q2 2025, and down 14.31% on a QoQ basis from -$147.5 million in Q1 2026.
Fortrea Holdings (FTRE) Enterprise Value (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Enterprise Value data on file, last reported at -$168.6 million in Q2 2026.
- Quarterly Enterprise Value fell 107.64% year-over-year to -$168.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$168.6 million (down 107.64% YoY) and the FY2025 annual result came in at -$174.6 million, down 47.34% from the prior year.
- Enterprise Value retreated to -$168.6 million in Q2 2026, from -$147.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$81.2 million in Q2 2025 to a low of -$174.6 million in Q4 2025.
- A 5-year average of -$120.7 million and a median of -$113.2 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2025 — Enterprise Value jumped 35.66% — and 2026, when it sank 107.64%.
- Tracing FTRE's Enterprise Value over 5 years: stood at -$112.0 million in 2022, then increased by 3.04% to -$108.6 million in 2023, then dropped by 9.12% to -$118.5 million in 2024, then sank by 47.34% to -$174.6 million in 2025, then grew by 3.44% to -$168.6 million in 2026.
- The last three Enterprise Value figures came in at -$168.6 million (Q2 2026), -$147.5 million (Q1 2026), and -$174.6 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn | -168.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -168.60 Mn |
| Mar 31, 2026 | -147.50 Mn |
| Dec 31, 2025 | -174.60 Mn |
| Sep 30, 2025 | -131.30 Mn |
| Jun 30, 2025 | -81.20 Mn |
| Mar 31, 2025 | -101.60 Mn |
| Dec 31, 2024 | -118.50 Mn |
| Sep 30, 2024 | -105.30 Mn |
| Jun 30, 2024 | -126.20 Mn |
| Mar 31, 2024 | -92.80 Mn |
| Dec 31, 2023 | -108.60 Mn |
| Sep 30, 2023 | -107.50 Mn |
| Jun 30, 2023 | -114.30 Mn |
| Dec 31, 2022 | -112.00 Mn |